Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.952345213417797e-47,30.387744976432646,3246.84516855498,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL9', 'RPL6', 'RPL7', 'RPS15', 'RPL7A', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS4Y1', 'RPS15A', 'RPL14', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS23']",1.5453669784463587e-44,0,0,57
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,9.73169634402825e-08,4.733010628222667,76.41584109918779,"['NDUFB9', 'ATP5PF', 'SURF1', 'COX7B', 'NDUFA7', 'NDUFB10', 'NDUFA4', 'COX17', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'COX7A2', 'UQCR10', 'COX7A1', 'COX7C', 'ATP5MC1', 'ATP5IF1', 'UQCRQ', 'NDUFS6', 'UQCRFS1', 'SLC25A5']",1.9025466352575228e-05,0,0,21
3,Nonalcoholic fatty liver disease WP4396,3.3222617942071432e-06,3.4019897188621466,42.91564016281886,"['NDUFB9', 'XBP1', 'COX7B', 'NDUFA7', 'TGFB1', 'NDUFB10', 'NDUFB11', 'NDUFA4', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'COX7A2', 'UQCR10', 'COX7A1', 'COX7C', 'BBC3', 'UQCRQ', 'NDUFS6', 'DDIT3', 'LEPR', 'CYCS', 'UQCRFS1', 'BAX']",0.0004330014538449977,0,0,23
4,"GPCRs, Class A Rhodopsin-like WP455",1.3009165907325428e-05,5.1048165892550195,57.428453471038715,"['GPR27', 'GPR12', 'P2RY14', 'CHRM5', 'OPRK1', 'ADRA1D', 'NMBR', 'HTR4', 'HTR5A', 'MCHR1', 'HCRTR2', 'HRH1', 'HTR7']",0.0012716459674410607,0,0,13
5,Cholesterol Biosynthesis Pathway WP197,1.982342026646051e-05,12.644630872483221,136.9242375569761,"['SQLE', 'NSDHL', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.001550191464837212,0,0,7
6,Mitochondrial CIV Assembly WP4922,6.242703993849113e-05,6.513189771197847,63.05752521537797,"['COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX17', 'COX7A2', 'COX14', 'COX7C', 'PET117']",0.004068162102658339,0,0,9
7,Monoamine GPCRs WP58,0.0005018182902733932,7.869607604192055,59.78755324326723,"['HRH1', 'HTR7', 'CHRM5', 'ADRA1D', 'HTR4', 'HTR5A']",0.028030135928128107,0,0,6
8,Allograft Rejection WP2328,0.0006350117047189791,5.945440189498618,43.76954068431452,"['ABCB1', 'TGFB1', 'COL5A1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F']",0.031036197068140106,0,0,7
9,ACE Inhibitor Pathway WP554,0.0010527874893810226,43.149532710280376,295.8467400650801,"['TGFB1', 'ATP6AP2', 'AGT']",0.04573776759421998,0,0,3
10,Oxidative phosphorylation WP623,0.00124368466970837,3.6165768194070083,24.19373003602668,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'ATP6AP1', 'NDUFB10', 'NDUFS6', 'NDUFA4', 'ATP6AP2', 'NDUFB2', 'ATP5MC1']",0.04862807058559727,0,0,10
11,TP53 network WP1742,0.00409648915862582,8.225362872421696,45.219960354898554,"['CDKN2A', 'GADD45A', 'BAX', 'BBC3']",0.11873555189794803,0,0,4
12,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.004251400835220646,inf,inf,"['TGFB1', 'VIP']",0.11873555189794803,0,0,2
13,COVID-19 adverse outcome pathway WP4891,0.004251400835220646,inf,inf,"['IL7', 'AGT']",0.11873555189794803,0,0,2
14,Gastric acid production WP2596,0.004251400835220646,inf,inf,"['CCK', 'VIP']",0.11873555189794803,0,0,2
15,Vitamin D Receptor Pathway WP2877,0.005069295616311491,2.890566037735849,15.275350590518109,"['ADAMTS5', 'SFRP1', 'ABCB1', 'TGFB1', 'IGFBP5', 'GADD45A', 'CDKN2A', 'PNOC', 'TIMP2', 'TIMP3']",0.1321396390651862,0,0,10
16,Statin inhibition of cholesterol production WP430,0.005830737368209956,7.196524064171123,37.0233226797198,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.1424886444356308,0,0,4
17,Mevalonate pathway WP3963,0.007937566992425234,10.78437917222964,52.15485888553345,"['HMGCS1', 'HMGCR', 'ACAT2']",0.18256404082578037,0,0,3
18,Peptide GPCRs WP24,0.010620989023991468,5.756149732620321,26.161258111728593,"['OPRK1', 'NMBR', 'ACKR1', 'HCRTR2']",0.22716876392837002,0,0,4
19,miR-509-3p alteration of YAP1/ECM axis WP3967,0.012089430532007802,8.626702269692924,38.090545808543155,"['COL5A1', 'PBX3', 'FN1']",0.22716876392837002,0,0,3
20,Photodynamic therapy-induced unfolded protein response WP3613,0.012113905233668551,4.23537286400504,18.692400075738597,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'BBC3']",0.22716876392837002,0,0,5
21,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.012200879904081254,28.728,126.5826697500079,"['BAX', 'IL6ST']",0.22716876392837002,0,0,2
22,Mitochondrial complex I assembly model OXPHOS system WP4324,0.013170535683349043,2.814843954891162,12.187635607142544,"['NDUFB9', 'NDUFA7', 'NDUFB10', 'NDUFS6', 'NDUFB11', 'NDUFB3', 'NDUFB2', 'NDUFA1']",0.23372545823232935,0,0,8
23,Mitochondrial complex III assembly WP4921,0.01374855636660761,5.232377248420029,22.430267032965702,"['UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR10']",0.23372545823232935,0,0,4
24,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.017265267857456773,7.1882510013351135,29.17753085111746,"['SFRP1', 'SST', 'DCN']",0.27898548884152796,0,0,3
25,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.01783794685687519,2.882953020134228,11.608000586182975,"['SQLE', 'NSDHL', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.27898548884152796,0,0,7
26,Cytokines and Inflammatory Response WP530,0.023349010655504692,14.362666666666666,53.96342076523159,"['TGFB1', 'IL7']",0.35113319870393594,0,0,2
27,Development of ureteric collection system WP5053,0.02440888147172236,3.42736023458915,12.725131245612603,"['SALL1', 'FRAS1', 'ETV4', 'GLI3', 'FREM2']",0.3534767650164238,0,0,5
28,Selenium Micronutrient Network WP15,0.031044049036392747,2.7872524431375942,9.678310854517699,"['SELENOM', 'PNPO', 'KMO', 'SEPHS2', 'LDLR', 'SELENOH']",0.4128533944784627,0,0,6
29,DNA Mismatch Repair WP531,0.03174535416749544,3.835650623885918,13.233028750509131,"['POLE4', 'RPA3', 'POLE2', 'POLE3']",0.4128533944784627,0,0,4
30,Unfolded protein response WP4925,0.03174535416749544,3.835650623885918,13.233028750509131,"['XBP1', 'HSPA5', 'DDIT3', 'BBC3']",0.4128533944784627,0,0,4
31,Senescence and Autophagy in Cancer WP615,0.034524505950268694,2.1629878869448182,7.280803005840722,"['TGFB1', 'MAP1LC3A', 'IGFBP5', 'CDKN2A', 'FN1', 'IGFBP7', 'IL6ST', 'CXCL14', 'SLC39A3']",0.4128533944784627,0,0,9
32,Dopaminergic Neurogenesis WP2855,0.03724565086905532,9.574222222222222,31.50129836071592,"['TGFB1', 'ASCL1']",0.4128533944784627,0,0,2
33,NAD Biosynthesis II (from tryptophan) WP2485,0.03724565086905532,9.574222222222222,31.50129836071592,"['NMNAT1', 'KMO']",0.4128533944784627,0,0,2
34,Cardiac Progenitor Differentiation WP2406,0.037695197198108266,3.5955882352941178,11.787138569798007,"['MESP1', 'TGFB1', 'TNNT2', 'THY1']",0.4128533944784627,0,0,4
35,miRNA targets in ECM and membrane receptors WP2911,0.03906796827545555,4.790832220738762,15.534045304845257,"['COL5A1', 'COL5A2', 'FN1']",0.4128533944784627,0,0,3
36,Nanomaterial induced apoptosis WP2507,0.03906796827545555,4.790832220738762,15.534045304845257,"['ENDOG', 'BAX', 'CYCS']",0.4128533944784627,0,0,3
37,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.03906796827545555,4.790832220738762,15.534045304845257,"['TGFB1', 'FN1', 'IGFBP7']",0.4128533944784627,0,0,3
38,Imatinib and Chronic Myeloid Leukemia WP3640,0.05869131006789439,3.919043573249181,11.112305409877473,"['SPRED2', 'ABCB1', 'GADD45A']",0.6039026904354395,0,0,3
39,Apoptosis Modulation and Signaling WP1772,0.06518637048752339,2.0996085011185683,5.732991244755042,"['HRK', 'ENDOG', 'CDKN2A', 'CYCS', 'BAX', 'PTPN13', 'BBC3']",0.6073865202074618,0,0,7
40,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.06524356483046903,inf,inf,['FMO5'],0.6073865202074618,0,0,1
41,Codeine and Morphine Metabolism WP1604,0.06524356483046903,inf,inf,['ABCB1'],0.6073865202074618,0,0,1
42,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.06524356483046903,inf,inf,['AGT'],0.6073865202074618,0,0,1
43,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.06992701067793035,3.5921228304405877,9.556136167842668,"['HMGCS1', 'HMGCR', 'LDLR']",0.6094917341763969,0,0,3
44,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.07051624730803424,2.056567593480345,5.453836562627307,"['TGFB1', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.6094917341763969,0,0,7
45,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.07170490990310552,5.7434666666666665,15.135160703722011,"['NSDHL', 'DHCR7']",0.6094917341763969,0,0,2
46,Dual hijack model of Vif in HIV infection WP3300,0.07170490990310552,5.7434666666666665,15.135160703722011,"['ELOB', 'RUNX1']",0.6094917341763969,0,0,2
47,IL-6 signaling pathway WP364,0.0824123624379408,2.319600984583495,5.789770040671832,"['PRKCD', 'GAB1', 'VIP', 'IL6ST', 'AGT']",0.6856007173028692,0,0,5
48,Base Excision Repair WP4752,0.08573239207454665,2.613514827418571,6.420163346475794,"['POLE4', 'APEX1', 'POLE2', 'POLE3']",0.6983617771072447,0,0,4
49,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.09157675837731477,4.785777777777778,11.440773962939955,"['SFRP1', 'TGFB1']",0.7143160063547772,0,0,2
50,Matrix Metalloproteinases WP129,0.09157675837731477,4.785777777777778,11.440773962939955,"['TIMP2', 'TIMP3']",0.7143160063547772,0,0,2
51,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.09499854815971462,3.0783902345985124,7.246203287096509,"['HTR7', 'RPS6KA5', 'HTR4']",0.7143160063547772,0,0,3
52,Sleep regulation WP3591,0.09499854815971462,3.0783902345985124,7.246203287096509,"['AHCY', 'CRH', 'HCRTR2']",0.7143160063547772,0,0,3
53,Oncostatin M Signaling Pathway WP2374,0.10515645755503109,1.9613697294662442,4.417604743066566,"['PRKCH', 'PRKCD', 'TIMP3', 'PTK2B', 'IL6ST', 'LDLR']",0.7652596655415237,0,0,6
54,"GPCRs, Other WP117",0.10619166369149069,2.395276292335116,5.371430246850743,"['HTR7', 'ADGRV1', 'ADRA1D', 'ACKR1']",0.7652596655415237,0,0,4
55,ATM Signaling Network in Development and Disease  WP3878,0.10764522149561075,2.11433971178833,4.712682326134627,"['DCLRE1C', 'KAT5', 'HSPB1', 'HMGN1', 'CDK5R1']",0.7652596655415237,0,0,5
56,Development and heterogeneity of the ILC family WP3893,0.11280863122259023,4.101714285714285,8.950196620593234,"['NFIL3', 'IL7']",0.7738276282111014,0,0,2
57,Major receptors targeted by epinephrine and norepinephrine WP4589,0.11280863122259023,4.101714285714285,8.950196620593234,"['ADCY10', 'ADRA1D']",0.7738276282111014,0,0,2
58,IL-18 signaling pathway WP4754,0.12064963118062431,1.462079258473744,3.09209958404778,"['CD81', 'RGS16', 'PRKCD', 'COX17', 'FN1', 'HSPB1', 'ADAMTS5', 'ARL4D', 'TIMP3', 'CYCS', 'BAX', 'CD36', 'ITM2C', 'ARF6']",0.7833306687949139,0,0,14
59,Composition of Lipid Particles WP3601,0.12623581408073076,14.344873501997338,29.688201566673342,['LDLR'],0.7833306687949139,0,0,1
60,Drug Induction of Bile Acid Pathway WP2289,0.12623581408073076,14.344873501997338,29.688201566673342,['ABCB1'],0.7833306687949139,0,0,1
61,EV release from cardiac cells and their functional effects WP3297,0.12623581408073076,14.344873501997338,29.688201566673342,['RGS16'],0.7833306687949139,0,0,1
62,DNA damage response WP707,0.1263215202301632,1.9965045366651792,4.130617897664936,"['GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.7833306687949139,0,0,5
63,Glycolysis in senescence WP5049,0.13513901880562848,3.5886666666666667,7.182541426964603,"['LDHA', 'ALDOC']",0.7833306687949139,0,0,2
64,Kynurenine Pathway and links to Cellular Senescence WP5044,0.13513901880562848,3.5886666666666667,7.182541426964603,"['KMO', 'ACMSD']",0.7833306687949139,0,0,2
65,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.13513901880562848,3.5886666666666667,7.182541426964603,"['HMGCS1', 'HMGCR']",0.7833306687949139,0,0,2
66,Endochondral Ossification with Skeletal Dysplasias WP4808,0.13618051926109925,1.9423640507977857,3.8726347990568986,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'GLI3']",0.7833306687949139,0,0,5
67,Endochondral Ossification WP474,0.13618051926109925,1.9423640507977857,3.8726347990568986,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'GLI3']",0.7833306687949139,0,0,5
68,Proteasome Degradation WP183,0.13820160970755202,1.7972520107238605,3.5568367106655496,"['H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB10']",0.7833306687949139,0,0,6
69,Genes controlling nephrogenesis WP4823,0.1382348239049848,2.5344380742951387,5.015149653840128,"['CD36', 'ETV4', 'GLI3']",0.7833306687949139,0,0,3
70,p38 MAPK Signaling Pathway WP400,0.14052382252096343,2.128540305010893,4.177001197251879,"['RPS6KA5', 'DDIT3', 'HSPB1', 'HMGN1']",0.7849259229385243,0,0,4
71,Pyrimidine metabolism WP4022,0.145373020263511,1.6778076062639822,3.2355719143918003,"['NT5C', 'POLE4', 'POLE2', 'POLR1C', 'POLE3', 'POLR2I', 'POLR2K']",0.7948622978691976,0,0,7
72,miRNA regulation of DNA damage response WP1530,0.14636850497847118,1.891073064186571,3.6339386297011966,"['GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.7948622978691976,0,0,5
73,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.15390064089851707,2.393413440142412,4.479148972273346,"['RAB3A', 'HSPB1', 'RAB11A']",0.814590201320026,0,0,3
74,Cori Cycle WP1946,0.1583346682872685,3.18962962962963,5.878628811226421,"['LDHA', 'PGAM1']",0.814590201320026,0,0,2
75,Overview of nanoparticle effects WP3287,0.1583346682872685,3.18962962962963,5.878628811226421,"['FN1', 'BAX']",0.814590201320026,0,0,2
76,Tryptophan catabolism leading to NAD+ production WP4210,0.1583346682872685,3.18962962962963,5.878628811226421,"['NMNAT1', 'KMO']",0.814590201320026,0,0,2
77,Aryl Hydrocarbon Receptor Pathway WP2873,0.1700882592702931,2.2672335043215517,4.016263141131901,"['TGFB1', 'AIP', 'BAX']",0.8331633644246829,0,0,3
78,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.1821880174494184,2.8704,4.88747618505002,"['CD81', 'HSPB1']",0.8331633644246829,0,0,2
79,GDNF/RET signaling axis WP4830,0.1821880174494184,2.8704,4.88747618505002,"['SALL1', 'GLI3']",0.8331633644246829,0,0,2
80,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.1821880174494184,2.8704,4.88747618505002,"['TGFB1', 'FN1']",0.8331633644246829,0,0,2
81,Type II diabetes mellitus WP1584,0.1821880174494184,2.8704,4.88747618505002,"['SURF1', 'PRKCD']",0.8331633644246829,0,0,2
82,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.1832533231215415,7.171770972037284,12.169676352128564,['ABCB1'],0.8331633644246829,0,0,1
83,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.1832533231215415,7.171770972037284,12.169676352128564,['CD247'],0.8331633644246829,0,0,1
84,Platelet-mediated interactions with vascular and circulating cells WP4462,0.1832533231215415,7.171770972037284,12.169676352128564,['TGFB1'],0.8331633644246829,0,0,1
85,Tgif disruption of Shh signaling WP3674,0.1832533231215415,7.171770972037284,12.169676352128564,['GLI3'],0.8331633644246829,0,0,1
86,Vitamin B6-dependent and responsive disorders WP4228,0.1832533231215415,7.171770972037284,12.169676352128564,['PNPO'],0.8331633644246829,0,0,1
87,Adipogenesis WP236,0.1975157944559192,1.5244254626804963,2.472521643833597,"['SFRP4', 'TGFB1', 'GADD45A', 'DDIT3', 'NDN', 'IL6ST', 'AGT']",0.8876859268076369,0,0,7
88,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.20378060914899868,2.050925042914362,3.2624296600695035,"['LDHA', 'ANGPT2', 'BAX']",0.9054342974688464,0,0,3
89,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.20651484236188977,2.609212121212121,4.115726825963076,"['BAX', 'BCL2L14']",0.9072730714999876,0,0,2
90,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.21627782280857188,1.5393527384144006,2.3570437994060915,"['SQLE', 'HMGCS1', 'INSIG1', 'HMGCR', 'LDLR', 'FDFT1']",0.9249291892920369,0,0,6
91,Bladder cancer WP2828,0.2211646037177348,1.957519116397621,2.953598884970794,"['RPS6KA5', 'CDKN2A', 'DAPK2']",0.9249291892920369,0,0,3
92,Apoptosis WP254,0.22557086370687585,1.5958649412464674,2.376435866208143,"['HRK', 'CDKN2A', 'CYCS', 'BAX', 'BBC3']",0.9249291892920369,0,0,5
93,Endometrial cancer WP4155,0.22557086370687585,1.5958649412464674,2.376435866208143,"['GADD45A', 'TCF7', 'BAX', 'FGF1', 'GADD45G']",0.9249291892920369,0,0,5
94,miRNA regulation of p53 pathway in prostate cancer WP3982,0.23115210202224015,2.3915555555555557,3.5028620003222817,"['BAX', 'BBC3']",0.9249291892920369,0,0,2
95,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.23389033523127475,1.6892104435357032,2.4542587966075,"['BEX3', 'HSPA5', 'HSPB1', 'PTK2B']",0.9249291892920369,0,0,4
96,Bile acids synthesis and enterohepatic circulation  WP4389,0.23655477987008616,4.780736795383932,6.891792895209022,['LDLR'],0.9249291892920369,0,0,1
97,FOXP3 in COVID-19 WP5063,0.23655477987008616,4.780736795383932,6.891792895209022,['IL6ST'],0.9249291892920369,0,0,1
98,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.23655477987008616,4.780736795383932,6.891792895209022,['FN1'],0.9249291892920369,0,0,1
99,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.23655477987008616,4.780736795383932,6.891792895209022,['LDLR'],0.9249291892920369,0,0,1
100,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.23655477987008616,4.780736795383932,6.891792895209022,['VEGFB'],0.9249291892920369,0,0,1
101,G1 to S cell cycle control WP45,0.24831834867068622,1.640794499618029,2.285698427585287,"['CDKN2A', 'GADD45A', 'RPA3', 'POLE2']",0.9331282391081859,0,0,4
102,One-carbon metabolism WP241,0.25595596443651636,2.2073846153846155,3.008113082686058,"['AHCY', 'CHDH']",0.9331282391081859,0,0,2
103,Striated Muscle Contraction Pathway WP383,0.25595596443651636,2.2073846153846155,3.008113082686058,"['TNNT2', 'ACTG1']",0.9331282391081859,0,0,2
104,Type II interferon signaling (IFNG) WP619,0.25595596443651636,2.2073846153846155,3.008113082686058,"['PRKCD', 'HLA-B']",0.9331282391081859,0,0,2
105,Glycolysis and Gluconeogenesis WP534,0.2567204273822829,1.7940587449933245,2.4395029851589243,"['LDHA', 'PGAM1', 'ALDOC']",0.9331282391081859,0,0,3
106,Nucleotide Excision Repair WP4753,0.2629308943697107,1.595068330362448,2.1307944244835255,"['POLE4', 'RPA3', 'POLE2', 'POLE3']",0.9331282391081859,0,0,4
107,DNA Replication WP466,0.2747838787743362,1.722136181575434,2.224604519431485,"['RPA3', 'POLE2', 'GMNN']",0.9331282391081859,0,0,3
108,GABA receptor Signaling WP4159,0.2747838787743362,1.722136181575434,2.224604519431485,"['SLC32A1', 'GAD1', 'GABRD']",0.9331282391081859,0,0,3
109,Tumor suppressor activity of SMARCB1 WP4204,0.2747838787743362,1.722136181575434,2.224604519431485,"['H3F3B', 'CDKN2A', 'GLI3']",0.9331282391081859,0,0,3
110,VEGFA-VEGFR2 Signaling Pathway WP3888,0.27481049377216643,1.1569149524319209,1.49435642331634,"['SET', 'TRAF3IP2', 'HSPB1', 'RPL10A', 'APOLD1', 'RPL7', 'HERPUD1', 'ACTG1', 'LDHA', 'RPS6KA5', 'RPL18A', 'RPLP2', 'DNAJB9', 'PTK2B', 'IGFBP7', 'MYH11', 'IER5', 'TRPC3', 'PRKCD', 'FN1', 'GAB1', 'RAB11A', 'CYCS', 'RPL26', 'ARF6']",0.9331282391081859,0,0,25
111,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.27769947476324486,1.551813845931493,1.9882083809050284,"['XBP1', 'MAP1LC3A', 'HSPA5', 'DDIT3']",0.9331282391081859,0,0,4
112,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.2807999993538466,2.0495238095238095,2.603126033191616,"['H3F3B', 'H2AFZ']",0.9331282391081859,0,0,2
113,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2807999993538466,2.0495238095238095,2.603126033191616,"['BAX', 'BBC3']",0.9331282391081859,0,0,2
114,Methionine De Novo and Salvage Pathway WP3580,0.2807999993538466,2.0495238095238095,2.603126033191616,"['AHCY', 'CHDH']",0.9331282391081859,0,0,2
115,Pre-implantation embryo WP3527,0.2807999993538466,2.0495238095238095,2.603126033191616,"['DLX2', 'DDIT3']",0.9331282391081859,0,0,2
116,Zinc homeostasis WP3529,0.2807999993538466,2.0495238095238095,2.603126033191616,"['SLC39A7', 'SLC39A3']",0.9331282391081859,0,0,2
117,Farnesoid X receptor pathway WP2879,0.28638206826849694,3.585219707057257,4.4830607450472675,['FKBP5'],0.9331282391081859,0,0,1
118,Inflammatory Response Pathway WP453,0.28638206826849694,3.585219707057257,4.4830607450472675,['FN1'],0.9331282391081859,0,0,1
119,Peroxiredoxin 2 induced ovarian failure WP4873,0.28638206826849694,3.585219707057257,4.4830607450472675,['BAX'],0.9331282391081859,0,0,1
120,Vitamin D Metabolism WP1531,0.28638206826849694,3.585219707057257,4.4830607450472675,['DHCR7'],0.9331282391081859,0,0,1
121,Differentiation Pathway WP2848,0.3055735248203328,1.912711111111111,2.2676430785302735,"['TGFB1', 'FGF1']",0.9502765525469558,0,0,2
122,NAD+ biosynthetic pathways WP3645,0.3055735248203328,1.912711111111111,2.2676430785302735,"['NMNAT1', 'ACMSD']",0.9502765525469558,0,0,2
123,Pancreatic adenocarcinoma pathway WP4263,0.30567000314423376,1.3459282841823057,1.595260395221696,"['TGFB1', 'CDKN2A', 'GADD45A', 'PRKCD', 'BAX', 'GADD45G']",0.9502765525469558,0,0,6
124,DNA IR-double strand breaks and cellular response via ATM WP3959,0.3075939171921035,1.4719594131358837,1.7354030791509374,"['DCLRE1C', 'KAT5', 'CDKN2A', 'BAX']",0.9502765525469558,0,0,4
125,Non-small cell lung cancer WP4255,0.3143149070009037,1.3801359283286994,1.597313989785809,"['CDKN2A', 'GADD45A', 'CYCS', 'BAX', 'GADD45G']",0.9502765525469558,0,0,5
126,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.3226662386363437,1.4350267379679145,1.6232115622223977,"['SFRP4', 'SFRP1', 'TCF7', 'CXXC4']",0.9502765525469558,0,0,4
127,Fas ligand pathway and stress induction of heat shock proteins WP314,0.32951989535008547,1.5371924470722869,1.7064658449382126,"['HSPB1', 'CYCS', 'ACTG1']",0.9502765525469558,0,0,3
128,Integrated Cancer Pathway WP1971,0.32951989535008547,1.5371924470722869,1.7064658449382126,"['BAX', 'BACH1', 'BBC3']",0.9502765525469558,0,0,3
129,White fat cell differentiation WP4149,0.33018009469518783,1.793,1.9868538381676115,"['DDIT3', 'NR2F2']",0.9502765525469558,0,0,2
130,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.3329613496136392,2.8679094540612518,3.1539228029994146,['TCF7'],0.9502765525469558,0,0,1
131,Biogenic Amine Synthesis WP550,0.3329613496136392,2.8679094540612518,3.1539228029994146,['GAD1'],0.9502765525469558,0,0,1
132,"Degradation pathway of sphingolipids, including diseases WP4153",0.3329613496136392,2.8679094540612518,3.1539228029994146,['NEU1'],0.9502765525469558,0,0,1
133,IL1 and megakaryocytes in obesity WP2865,0.3329613496136392,2.8679094540612518,3.1539228029994146,['TIMP2'],0.9502765525469558,0,0,1
134,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3329613496136392,2.8679094540612518,3.1539228029994146,['AHCY'],0.9502765525469558,0,0,1
135,Selective expression of chemokine receptors during T-cell polarization WP4494,0.3329613496136392,2.8679094540612518,3.1539228029994146,['TGFB1'],0.9502765525469558,0,0,1
136,Sulfation Biotransformation Reaction WP692,0.3329613496136392,2.8679094540612518,3.1539228029994146,['PAPSS2'],0.9502765525469558,0,0,1
137,Transcriptional cascade regulating adipogenesis WP4211,0.3329613496136392,2.8679094540612518,3.1539228029994146,['DDIT3'],0.9502765525469558,0,0,1
138,Breast cancer pathway WP4262,0.3397677557288159,1.256006711409396,1.3558504104128255,"['SFRP4', 'SHC3', 'GADD45A', 'TCF7', 'BAX', 'FGF1', 'GADD45G']",0.9626753078983118,0,0,7
139,Acute viral myocarditis WP4298,0.35293366415171956,1.3664374840845428,1.42311069730976,"['ENDOG', 'TGFB1', 'CYCS', 'BAX']",0.9745713702812088,0,0,4
140,Angiogenesis WP1539,0.3545361164252208,1.6873725490196079,1.7497126262126832,"['TIMP2', 'TIMP3']",0.9745713702812088,0,0,2
141,IL-7 signaling pathway WP205,0.3545361164252208,1.6873725490196079,1.7497126262126832,"['IL7', 'PTK2B']",0.9745713702812088,0,0,2
142,Prader-Willi and Angelman Syndrome WP3998,0.36602270228199746,1.434445927903872,1.4417041086992832,"['CDKN2A', 'NDN', 'GABRD']",0.9745713702812088,0,0,3
143,Cancer immunotherapy by PD-1 blockade WP4585,0.37650408186612444,2.3897026187305817,2.334324582684732,['HLA-A'],0.9745713702812088,0,0,1
144,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.37650408186612444,2.3897026187305817,2.334324582684732,['GALNT3'],0.9745713702812088,0,0,1
145,HIF1A and PPARG regulation of glycolysis WP2456,0.37650408186612444,2.3897026187305817,2.334324582684732,['LDHA'],0.9745713702812088,0,0,1
146,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.37650408186612444,2.3897026187305817,2.334324582684732,['TGFB1'],0.9745713702812088,0,0,1
147,Osteoclast Signaling WP12,0.37650408186612444,2.3897026187305817,2.334324582684732,['AIMP2'],0.9745713702812088,0,0,1
148,Thiamine metabolic pathways WP4297,0.37650408186612444,2.3897026187305817,2.334324582684732,['BCKDK'],0.9745713702812088,0,0,1
149,Endothelin Pathways WP2197,0.3785695878434787,1.5934814814814815,1.5478367962144646,"['ADCY10', 'MYLK']",0.9745713702812088,0,0,2
150,Folate Metabolism WP176,0.3785695878434787,1.5934814814814815,1.5478367962144646,"['AHCY', 'LDLR']",0.9745713702812088,0,0,2
151,Physiological and pathological hypertrophy of the heart WP1528,0.3785695878434787,1.5934814814814815,1.5478367962144646,"['IL6ST', 'AGT']",0.9745713702812088,0,0,2
152,Genotoxicity pathway WP4286,0.38415958497686054,1.388044274085878,1.3279381077616788,"['RPS27', 'GADD45A', 'PCDH8']",0.9745713702812088,0,0,3
153,DNA damage response (only ATM dependent) WP710,0.38826032137232913,1.2124381678812823,1.1470625718814145,"['TGFB1', 'CDKN2A', 'TCF7', 'BAX', 'LDLR', 'BBC3']",0.9745713702812088,0,0,6
154,Lung fibrosis WP3624,0.4022189440209736,1.5094736842105263,1.3747662929662017,"['TGFB1', 'FGF1']",0.9745713702812088,0,0,2
155,Small cell lung cancer WP4658,0.40658899095251216,1.2155968506795545,1.0939793688697068,"['GADD45A', 'FN1', 'CYCS', 'BAX', 'GADD45G']",0.9745713702812088,0,0,5
156,Myometrial relaxation and contraction pathways WP289,0.4083536531434947,1.147741935483871,1.0279425640330193,"['PRKCH', 'IGFBP5', 'RGS16', 'PRKCD', 'CRH', 'ATF5', 'CORIN', 'ACTG1']",0.9745713702812088,0,0,8
157,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.41330732040991736,1.2471518251569402,1.1019382625876395,"['ANGPT2', 'FN1', 'BAX', 'ANGPTL1']",0.9745713702812088,0,0,4
158,Galanin receptor pathway WP4970,0.41720797365818335,2.0481263077801026,1.7904114832714113,['PRKCD'],0.9745713702812088,0,0,1
159,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.41720797365818335,2.0481263077801026,1.7904114832714113,['ELOB'],0.9745713702812088,0,0,1
160,Leptin and adiponectin WP3934,0.41720797365818335,2.0481263077801026,1.7904114832714113,['LEPR'],0.9745713702812088,0,0,1
161,Mitochondrial CII Assembly WP4920,0.41720797365818335,2.0481263077801026,1.7904114832714113,['SDHAF1'],0.9745713702812088,0,0,1
162,Serotonin and anxiety-related events WP3944,0.41720797365818335,2.0481263077801026,1.7904114832714113,['CRH'],0.9745713702812088,0,0,1
163,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.41720797365818335,2.0481263077801026,1.7904114832714113,['TGFB1'],0.9745713702812088,0,0,1
164,Trans-sulfuration pathway WP2333,0.41720797365818335,2.0481263077801026,1.7904114832714113,['AHCY'],0.9745713702812088,0,0,1
165,MTHFR deficiency WP4288,0.42543200486925237,1.4338666666666666,1.2254543535456275,"['CHDH', 'CYCS']",0.9745713702812088,0,0,2
166,Oxysterols derived from cholesterol WP4545,0.42543200486925237,1.4338666666666666,1.2254543535456275,"['INSIG1', 'DHCR7']",0.9745713702812088,0,0,2
167,Ebola Virus Pathway on Host WP4217,0.44741047931140365,1.1321433610836744,0.9105589123834695,"['HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'ASGR1', 'ACTG1']",0.9745713702812088,0,0,6
168,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4481650151347072,1.3654603174603175,1.0959099535783976,"['TGFB1', 'BAX']",0.9745713702812088,0,0,2
169,15q11.2 copy number variation syndrome WP4940,0.4552578771618359,1.7919440745672437,1.4100651263629136,['TUBGCP4'],0.9745713702812088,0,0,1
170,Alanine and aspartate metabolism WP106,0.4552578771618359,1.7919440745672437,1.4100651263629136,['GAD1'],0.9745713702812088,0,0,1
171,Biomarkers for pyrimidine metabolism disorders WP4584,0.4552578771618359,1.7919440745672437,1.4100651263629136,['NT5C'],0.9745713702812088,0,0,1
172,Hypertrophy Model WP516,0.4552578771618359,1.7919440745672437,1.4100651263629136,['WDR1'],0.9745713702812088,0,0,1
173,Non-homologous end joining WP438,0.4552578771618359,1.7919440745672437,1.4100651263629136,['DCLRE1C'],0.9745713702812088,0,0,1
174,Purine metabolism WP4792,0.4552578771618359,1.7919440745672437,1.4100651263629136,['PRPS1'],0.9745713702812088,0,0,1
175,Pyrimidine metabolism and related diseases WP4225,0.4552578771618359,1.7919440745672437,1.4100651263629136,['NT5C'],0.9745713702812088,0,0,1
176,RAS and bradykinin pathways in COVID-19 WP4969,0.4552578771618359,1.7919440745672437,1.4100651263629136,['AGT'],0.9745713702812088,0,0,1
177,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.45779582134148245,1.1704681872749099,0.9145242487632418,"['SFRP4', 'SFRP1', 'TCF7', 'CXXC4']",0.9745713702812088,0,0,4
178,Melanoma WP4685,0.4723789179214213,1.146951871657754,0.8601838802772033,"['CDKN2A', 'GADD45A', 'BAX', 'GADD45G']",0.9745713702812088,0,0,4
179,Exercise-induced Circadian Regulation WP410,0.48940890568255924,1.1623064987550968,0.8305341646254605,"['PER2', 'RBPMS', 'HERPUD1']",0.9745713702812088,0,0,3
180,Canonical and non-canonical TGF-B signaling WP3874,0.49082662280930356,1.5926912265127977,1.1334615249196387,['TGFB1'],0.9745713702812088,0,0,1
181,Computational Model of Aerobic Glycolysis WP4629,0.49082662280930356,1.5926912265127977,1.1334615249196387,['LDHA'],0.9745713702812088,0,0,1
182,Cysteine and methionine catabolism WP4504,0.49082662280930356,1.5926912265127977,1.1334615249196387,['AHCY'],0.9745713702812088,0,0,1
183,Fatty acid transporters WP5061,0.49082662280930356,1.5926912265127977,1.1334615249196387,['CD36'],0.9745713702812088,0,0,1
184,"GPCRs, Class B Secretin-like WP334",0.49082662280930356,1.5926912265127977,1.1334615249196387,['ADGRG2'],0.9745713702812088,0,0,1
185,Hedgehog Signaling Pathway Netpath WP47,0.49082662280930356,1.5926912265127977,1.1334615249196387,['GLI3'],0.9745713702812088,0,0,1
186,Nuclear receptors WP170,0.4920528176812363,1.2464927536231885,0.8839742878906844,"['NR2E1', 'NR2F2']",0.9745713702812088,0,0,2
187,Oxidative Damage WP3941,0.4920528176812363,1.2464927536231885,0.8839742878906844,"['GADD45A', 'CYCS']",0.9745713702812088,0,0,2
188,Spinal Cord Injury WP2431,0.5010844207418712,1.1026326614561908,0.7618978746028037,"['TGFB1', 'GADD45A', 'APEX1', 'GFAP']",0.9745713702812088,0,0,4
189,Modulators of TCR signaling and T cell activation WP5072,0.5061227999675857,1.1316140819338065,0.7706019761254155,"['NDUFB10', 'ELOB', 'CD247']",0.9745713702812088,0,0,3
190,p53 transcriptional gene network WP4963,0.5061227999675857,1.1316140819338065,0.7706019761254155,"['GADD45A', 'BAX', 'BBC3']",0.9745713702812088,0,0,3
191,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.5061227999675857,1.1316140819338065,0.7706019761254155,"['EIF4A2', 'RPS6KA5', 'PRKCD']",0.9745713702812088,0,0,3
192,Alpha 6 Beta 4 signaling pathway WP244,0.5131547352823996,1.1944444444444444,0.7969068776564554,"['PRKCD', 'GAB1']",0.9745713702812088,0,0,2
193,Complement system WP2806,0.5131547352823996,1.1944444444444444,0.7969068776564554,"['RPS19', 'DCN']",0.9745713702812088,0,0,2
194,Phosphodiesterases in neuronal function WP4222,0.5225479140678077,1.1024956352059156,0.7155622211351762,"['ADCY10', 'PDE5A', 'PDE6B']",0.9745713702812088,0,0,3
195,BMP Signaling Pathway in Eyelid Development WP3927,0.5240758004074746,1.433288948069241,0.9260751471012424,['SFRP1'],0.9745713702812088,0,0,1
196,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5240758004074746,1.433288948069241,0.9260751471012424,['CCK'],0.9745713702812088,0,0,1
197,Leptin Insulin Overlap WP3935,0.5240758004074746,1.433288948069241,0.9260751471012424,['LEPR'],0.9745713702812088,0,0,1
198,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.5240758004074746,1.433288948069241,0.9260751471012424,['IL6ST'],0.9745713702812088,0,0,1
199,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5240758004074746,1.433288948069241,0.9260751471012424,['SFRP4'],0.9745713702812088,0,0,1
200,Serotonin and anxiety WP3947,0.5240758004074746,1.433288948069241,0.9260751471012424,['CRH'],0.9745713702812088,0,0,1
201,TYROBP causal network in microglia WP3945,0.5240758004074746,1.433288948069241,0.9260751471012424,['LHFPL2'],0.9745713702812088,0,0,1
202,Retinoblastoma gene in cancer WP2446,0.5290887400887874,1.0615963557140027,0.6758112958127503,"['ANLN', 'H2AFZ', 'RPA3', 'POLE2']",0.9745713702812088,0,0,4
203,T-cell receptor (TCR) signaling pathway WP69,0.5290887400887874,1.0615963557140027,0.6758112958127503,"['TGFB1', 'PRKCD', 'PTK2B', 'CD247']",0.9745713702812088,0,0,4
204,BDNF-TrkB Signaling WP3676,0.5336694684329869,1.14656,0.7200151489322916,"['TRPC3', 'GAB1']",0.9745713702812088,0,0,2
205,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5336694684329869,1.14656,0.7200151489322916,"['PRKCH', 'PRKCD']",0.9745713702812088,0,0,2
206,Proximal tubule transport WP4917,0.5336694684329869,1.14656,0.7200151489322916,"['ABCB1', 'SLC3A1']",0.9745713702812088,0,0,2
207,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5544745589627774,1.0485199778566543,0.6183482520964901,"['IFI27L2', 'PRKCH', 'PRKCD']",0.9745713702812088,0,0,3
208,Airway smooth muscle cell contraction WP4962,0.555156488816511,1.3028689020699673,0.7667451800025468,['MYLK'],0.9745713702812088,0,0,1
209,ERK Pathway in Huntington's Disease WP3853,0.555156488816511,1.3028689020699673,0.7667451800025468,['RPS6KA5'],0.9745713702812088,0,0,1
210,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.555156488816511,1.3028689020699673,0.7667451800025468,['ABCB1'],0.9745713702812088,0,0,1
211,Phytochemical activity on NRF2 transcriptional activation WP3,0.555156488816511,1.3028689020699673,0.7667451800025468,['AIMP2'],0.9745713702812088,0,0,1
212,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.555156488816511,1.3028689020699673,0.7667451800025468,['LDHA'],0.9745713702812088,0,0,1
213,NRF2 pathway WP2884,0.5584787040620303,1.0090125761261006,0.5877889670035257,"['TGFB1', 'SLC2A12', 'SLC39A7', 'SLC39A3', 'CBR3']",0.9745713702812088,0,0,5
214,MECP2 and Associated Rett Syndrome WP3584,0.5695881322856943,1.0054414110141665,0.5659044075949531,"['SST', 'GAD1', 'OPRK1', 'FKBP5']",0.9745713702812088,0,0,4
215,AGE/RAGE pathway WP2324,0.5699521839428362,1.0234598512302118,0.575392003763794,"['PRKCD', 'CYCS', 'TIRAP']",0.9745713702812088,0,0,3
216,Hedgehog Signaling Pathway WP4249,0.5728884683965473,1.0614320987654322,0.5912858508108007,"['HHIP', 'GLI3']",0.9745713702812088,0,0,2
217,Type 2 papillary renal cell carcinoma WP4241,0.5728884683965473,1.0614320987654322,0.5912858508108007,"['TGFB1', 'ELOB']",0.9745713702812088,0,0,2
218,Calcium Regulation in the Cardiac Cell WP536,0.5730500145500156,0.9830767206211344,0.5473596985603233,"['GJD2', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'ATP1B2']",0.9745713702812088,0,0,7
219,Apoptosis Modulation by HSP70 WP384,0.5842099393421306,1.194185530403906,0.6418686030819051,['CYCS'],0.9745713702812088,0,0,1
220,Globo Sphingolipid Metabolism WP1424,0.5842099393421306,1.194185530403906,0.6418686030819051,['B3GALNT1'],0.9745713702812088,0,0,1
221,Heart Development WP1591,0.5842099393421306,1.194185530403906,0.6418686030819051,['VEGFB'],0.9745713702812088,0,0,1
222,Kallmann's Syndrome WP5074,0.5842099393421306,1.194185530403906,0.6418686030819051,['ASCL1'],0.9745713702812088,0,0,1
223,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.5842099393421306,1.194185530403906,0.6418686030819051,['GADD45G'],0.9745713702812088,0,0,1
224,NAD+ metabolism WP3644,0.5842099393421306,1.194185530403906,0.6418686030819051,['NMNAT1'],0.9745713702812088,0,0,1
225,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.5842099393421306,1.194185530403906,0.6418686030819051,['ASCL1'],0.9745713702812088,0,0,1
226,Synaptic Vesicle Pathway WP2267,0.5850930009008587,0.9995653118887199,0.5357514824104239,"['RAB3A', 'SLC32A1', 'CPLX3']",0.9745713702812088,0,0,3
227,Translation Factors WP107,0.5850930009008587,0.9995653118887199,0.5357514824104239,"['EIF4A2', 'EEF1B2', 'EEF1G']",0.9745713702812088,0,0,3
228,Copper homeostasis WP3286,0.5915783491279548,1.0234285714285714,0.5372602356673764,"['COX17', 'ATOX1']",0.9745713702812088,0,0,2
229,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.5915783491279548,1.0234285714285714,0.5372602356673764,"['IFITM3', 'DDIT3']",0.9745713702812088,0,0,2
230,Parkinson's disease pathway WP2371,0.5915783491279548,1.0234285714285714,0.5372602356673764,"['CYCS', 'UBE2L6']",0.9745713702812088,0,0,2
231,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.595480167869529,0.971177376960029,0.5034459153837346,"['TGFB1', 'IL6ST', 'AGT', 'MYLK']",0.9745713702812088,0,0,4
232,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6096513323860606,0.9880459770114942,0.4889524071820289,"['MAP1LC3A', 'IGFBP5']",0.9745713702812088,0,0,2
233,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6096513323860606,0.9880459770114942,0.4889524071820289,"['GAB1', 'PTK2B']",0.9745713702812088,0,0,2
234,Target Of Rapamycin (TOR) Signaling WP1471,0.6096513323860606,0.9880459770114942,0.4889524071820289,"['RRAGA', 'HMGCR']",0.9745713702812088,0,0,2
235,Pregnane X receptor pathway WP2876,0.6113682137360938,1.1022226774557,0.542355127672555,['ABCB1'],0.9745713702812088,0,0,1
236,Purinergic signaling WP4900,0.6113682137360938,1.1022226774557,0.542355127672555,['P2RY14'],0.9745713702812088,0,0,1
237,Vitamin B12 metabolism WP1533,0.6113682137360938,1.1022226774557,0.542355127672555,['LDLR'],0.9745713702812088,0,0,1
238,Endoderm differentiation WP2853,0.6131924382963848,0.944200571546416,0.46178627646656506,"['DUSP4', 'SFRP1', 'TGFB1', 'TCF7', 'SLC2A12', 'PBX3']",0.9745713702812088,0,0,6
239,Wnt signaling pathway and pluripotency WP399,0.6204227484313614,0.9391601648110809,0.44831203129184793,"['PRKCH', 'PRKCD', 'TCF7', 'LDLR']",0.9745713702812088,0,0,4
240,Aryl Hydrocarbon Receptor Netpath WP2586,0.6271082558414894,0.9550222222222222,0.44564784176087485,"['AIP', 'CD36']",0.9745713702812088,0,0,2
241,Nephrotic syndrome WP4758,0.6271082558414894,0.9550222222222222,0.44564784176087485,"['ANLN', 'GPC5']",0.9745713702812088,0,0,2
242,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.6271082558414894,0.9550222222222222,0.44564784176087485,"['CDKN2A', 'BAX']",0.9745713702812088,0,0,2
243,Constitutive Androstane Receptor Pathway WP2875,0.6367547815996553,1.0233973749286664,0.46193154423251415,['ABCB1'],0.9745713702812088,0,0,1
244,Gastric Cancer Network 1 WP2361,0.6367547815996553,1.0233973749286664,0.46193154423251415,['KIF15'],0.9745713702812088,0,0,1
245,Hematopoietic Stem Cell Differentiation WP2849,0.6367547815996553,1.0233973749286664,0.46193154423251415,['RUNX1'],0.9745713702812088,0,0,1
246,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6367547815996553,1.0233973749286664,0.46193154423251415,['MYLK'],0.9745713702812088,0,0,1
247,Toll-like Receptor Signaling related to MyD88 WP3858,0.6367547815996553,1.0233973749286664,0.46193154423251415,['TIRAP'],0.9745713702812088,0,0,1
248,Vitamin A and carotenoid metabolism WP716,0.6367547815996553,1.0233973749286664,0.46193154423251415,['CD36'],0.9745713702812088,0,0,1
249,Circadian rhythm related genes WP3594,0.6368702017511242,0.9235171696149844,0.416681166038212,"['PER2', 'HTR7', 'AHCY', 'NFIL3', 'CRH', 'ATF5', 'RPS27A', 'HCRTR2']",0.9745713702812088,0,0,8
250,One-carbon metabolism and related pathways WP3940,0.6439524707912516,0.9241290322580645,0.40673724247180937,"['CHDH', 'GAD1']",0.9745713702812088,0,0,2
251,Male infertility WP4673,0.6443763191097123,0.9091757915287327,0.3995576463031175,"['ABCB1', 'PEX10', 'TEX15', 'ETV5']",0.9745713702812088,0,0,4
252,Osteoblast differentiation WP4787,0.6443763191097123,0.9091757915287327,0.3995576463031175,"['PRKCH', 'PRKCD', 'FGF1', 'GLI3']",0.9745713702812088,0,0,4
253,Nuclear Receptors Meta-Pathway WP2882,0.649227051385447,0.9173059644757758,0.39625120337389563,"['ABCB1', 'TGFB1', 'B3GNT5', 'SLC2A12', 'AIP', 'BAX', 'SLC39A7', 'CBR3', 'SLC39A3', 'FKBP5']",0.9745713702812088,0,0,10
254,DNA Repair Pathways Full Network WP4946,0.6524936357711725,0.9041061097784676,0.38601162365303826,"['POLE4', 'DCLRE1C', 'RPA3', 'POLE2', 'APEX1', 'POLE3']",0.9745713702812088,0,0,6
255,Glioblastoma signaling pathways WP2261,0.6559731451644821,0.8948863636363636,0.37731579505527985,"['PRKCH', 'CDKN2A', 'PRKCD', 'GAB1']",0.9745713702812088,0,0,4
256,Wnt signaling WP428,0.6559731451644821,0.8948863636363636,0.37731579505527985,"['SFRP4', 'SFRP1', 'TCF7', 'CXXC4']",0.9745713702812088,0,0,4
257,Cytosolic DNA-sensing pathway WP4655,0.6601895115147727,0.8951666666666667,0.3716985748592241,"['POLR1C', 'POLR2K']",0.9745713702812088,0,0,2
258,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.660485078447407,0.9550821127385708,0.39614967176055105,['FGF1'],0.9745713702812088,0,0,1
259,Immune response to tuberculosis WP4197,0.660485078447407,0.9550821127385708,0.39614967176055105,['IFIT3'],0.9745713702812088,0,0,1
260,Monoamine Transport WP727,0.660485078447407,0.9550821127385708,0.39614967176055105,['AGT'],0.9745713702812088,0,0,1
261,Nucleotide metabolism WP404,0.660485078447407,0.9550821127385708,0.39614967176055105,['PRPS1'],0.9745713702812088,0,0,1
262,Proteoglycan biosynthesis WP4784,0.660485078447407,0.9550821127385708,0.39614967176055105,['PAPSS2'],0.9745713702812088,0,0,1
263,SARS-CoV-2 mitochondrial interactions WP5038,0.660485078447407,0.9550821127385708,0.39614967176055105,['NDUFB9'],0.9745713702812088,0,0,1
264,Hepatitis B infection WP4666,0.6619270402486493,0.8946045576407506,0.36911378700631436,"['TGFB1', 'ATP6AP1', 'CYCS', 'PTK2B', 'BAX', 'TIRAP']",0.9745713702812088,0,0,6
265,Interleukin-11 Signaling Pathway WP2332,0.6758267967883937,0.8679595959595959,0.34008258662166313,"['TGFB1', 'IL6ST']",0.9745713702812088,0,0,2
266,7-oxo-C and 7beta-HC pathways WP5064,0.6826670282320642,0.895306258322237,0.3417814199273655,['DHCR7'],0.9745713702812088,0,0,1
267,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6826670282320642,0.895306258322237,0.3417814199273655,['H3F3B'],0.9745713702812088,0,0,1
268,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6826670282320642,0.895306258322237,0.3417814199273655,['TIRAP'],0.9745713702812088,0,0,1
269,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6826670282320642,0.895306258322237,0.3417814199273655,['ANGPT2'],0.9745713702812088,0,0,1
270,Purine metabolism and related disorders WP4224,0.6826670282320642,0.895306258322237,0.3417814199273655,['PRPS1'],0.9745713702812088,0,0,1
271,TLR4 Signaling and Tolerance WP3851,0.6826670282320642,0.895306258322237,0.3417814199273655,['TIRAP'],0.9745713702812088,0,0,1
272,Pathways Regulating Hippo Signaling WP4540,0.6892164414790388,0.8545773804772927,0.3180736315565184,"['PRKCH', 'PRKD3', 'PRKCD', 'TCF7']",0.9745713702812088,0,0,4
273,Metabolic reprogramming in colon cancer WP4290,0.6908733612358858,0.8423529411764706,0.3115010569932919,"['LDHA', 'PGAM1']",0.9745713702812088,0,0,2
274,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6992874982663426,0.863295533441333,0.3087950471632089,"['LINGO1', 'RAB3A', 'RPS6KA5', 'SHC3', 'PRKCD', 'PTK2B', 'CDK5R1']",0.9745713702812088,0,0,7
275,16p11.2 distal deletion syndrome WP4950,0.7034015308945905,0.8425628573666484,0.29643668471886214,['CD81'],0.9745713702812088,0,0,1
276,1q21.1 copy number variation syndrome WP4905,0.7034015308945905,0.8425628573666484,0.29643668471886214,['FMO5'],0.9745713702812088,0,0,1
277,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7034015308945905,0.8425628573666484,0.29643668471886214,['LDHA'],0.9745713702812088,0,0,1
278,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.7034015308945905,0.8425628573666484,0.29643668471886214,['MAP1LC3A'],0.9745713702812088,0,0,1
279,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7034015308945905,0.8425628573666484,0.29643668471886214,['B3GALNT1'],0.9745713702812088,0,0,1
280,Oxidation by Cytochrome P450 WP43,0.7034015308945905,0.8425628573666484,0.29643668471886214,['CYB5R1'],0.9745713702812088,0,0,1
281,Trans-sulfuration and one-carbon metabolism WP2525,0.7034015308945905,0.8425628573666484,0.29643668471886214,['AHCY'],0.9745713702812088,0,0,1
282,Tryptophan metabolism WP465,0.7034015308945905,0.8425628573666484,0.29643668471886214,['ACMSD'],0.9745713702812088,0,0,1
283,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.705380301252128,0.8258703912909521,0.2882437868405329,"['HSPA5', 'UBE2L6', 'HSPA1B']",0.9745713702812088,0,0,3
284,Head and Neck Squamous Cell Carcinoma WP4674,0.7169442066111048,0.8102123586165202,0.2696040416012243,"['CDKN2A', 'GAB1', 'FAT1']",0.9820056289110735,0,0,3
285,Glycerolipids and Glycerophospholipids WP4722,0.7227829197727638,0.7956798342950141,0.2583145549146957,['CDIPT'],0.9820056289110735,0,0,1
286,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7227829197727638,0.7956798342950141,0.2583145549146957,['TRPC3'],0.9820056289110735,0,0,1
287,Eukaryotic Transcription Initiation WP405,0.7325784022535783,0.7738378378378379,0.2408066579417724,"['POLR2I', 'POLR2K']",0.9820056289110735,0,0,2
288,Histone Modifications WP2369,0.7325784022535783,0.7738378378378379,0.2408066579417724,"['SET', 'H3F3B']",0.9820056289110735,0,0,2
289,IL-4 signaling pathway WP395,0.7325784022535783,0.7738378378378379,0.2408066579417724,"['HRH1', 'NFIL3']",0.9820056289110735,0,0,2
290,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.7325784022535783,0.7738378378378379,0.2408066579417724,"['TGFB1', 'TCF7']",0.9820056289110735,0,0,2
291,MAPK Signaling Pathway WP382,0.7326042139167017,0.8508214606597356,0.2647328223727875,"['DUSP4', 'RPS6KA5', 'TGFB1', 'GADD45A', 'DDIT3', 'PRKCD', 'HSPB1', 'FGF1', 'HSPA1B', 'DUSP7']",0.9820056289110735,0,0,10
292,Cell cycle WP179,0.7394242244809927,0.7948603683897801,0.2399552067052265,"['TGFB1', 'GADD45A', 'CDKN2A', 'GADD45G']",0.9820056289110735,0,0,4
293,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7408993875416028,0.7537318662835517,0.22603698268074116,['TGFB1'],0.9820056289110735,0,0,1
294,Glycosylation and related congenital defects WP4521,0.7408993875416028,0.7537318662835517,0.22603698268074116,['DPM3'],0.9820056289110735,0,0,1
295,NRF2-ARE regulation WP4357,0.7408993875416028,0.7537318662835517,0.22603698268074116,['AIMP2'],0.9820056289110735,0,0,1
296,Regulation of Microtubule Cytoskeleton WP2038,0.7453767806077014,0.7534035087719299,0.2213992556119253,"['SPRED1', 'PARD6A']",0.984602436545984,0,0,2
297,Alzheimer's disease WP2059,0.7495227092958012,0.7665935533091741,0.2210232280769541,"['ATP5MD', 'CYCS', 'CDK5R1']",0.9867453849651793,0,0,3
298,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7576461990816464,0.734017094017094,0.20371819272199884,"['ADCY10', 'TGFB1']",0.9910128895712292,0,0,2
299,Nanoparticle triggered autophagic cell death WP2509,0.7578333861427047,0.7159786950732356,0.1985349672056756,['MAP1LC3A'],0.9910128895712292,0,0,1
300,Insulin Signaling WP481,0.7661860437030706,0.800461744966443,0.2131871861253378,"['XBP1', 'RPS6KA5', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1', 'ARF6']",0.9984282791802614,0,0,7
301,Ethanol effects on histone modifications WP3996,0.7736619995681768,0.6818210639781878,0.174969053598845,['AHCY'],0.9984282791802614,0,0,1
302,Integrated breast cancer pathway WP1984,0.7765529341995843,0.7797221545210822,0.19718430093038125,"['GADD45A', 'BAX', 'HMGCR', 'FAU', 'JAKMIP1', 'BACH1']",0.9984282791802614,0,0,6
303,Focal Adhesion WP306,0.7794723811866088,0.7877080801141468,0.19624803343385577,"['RELN', 'SHC3', 'COL5A2', 'FN1', 'VEGFB', 'MYLK', 'ACTG1']",0.9984282791802614,0,0,7
304,IL17 signaling pathway WP2112,0.7884572930837944,0.6507686720735988,0.15467276927786275,['TRAF3IP2'],0.9984282791802614,0,0,1
305,Neovascularisation processes WP4331,0.7884572930837944,0.6507686720735988,0.15467276927786275,['TGFB1'],0.9984282791802614,0,0,1
306,Sphingolipid pathway WP1422,0.7884572930837944,0.6507686720735988,0.15467276927786275,['SERINC1'],0.9984282791802614,0,0,1
307,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8022866395984473,0.6224164881607133,0.13711171052725993,['AGT'],0.9984282791802614,0,0,1
308,Signal transduction through IL1R WP4496,0.8022866395984473,0.6224164881607133,0.13711171052725993,['TGFB1'],0.9984282791802614,0,0,1
309,The influence of laminopathies on Wnt signaling WP4844,0.8022866395984473,0.6224164881607133,0.13711171052725993,['TCF7'],0.9984282791802614,0,0,1
310,Pathways in clear cell renal cell carcinoma WP4018,0.805610674752727,0.6920194668159697,0.14958325123330438,"['LDHA', 'TGFB1', 'ALDOC']",0.9984282791802614,0,0,3
311,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8115749787280838,0.6503030303030303,0.13576929190597833,"['FN1', 'MYLK']",0.9984282791802614,0,0,2
312,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8115749787280838,0.6503030303030303,0.13576929190597833,"['TGFB1', 'FAT1']",0.9984282791802614,0,0,2
313,B Cell Receptor Signaling Pathway WP23,0.8138528287550005,0.6809714540021616,0.1402635919258572,"['CD81', 'PRKCD', 'GAB1']",0.9984282791802614,0,0,3
314,Corticotropin-releasing hormone signaling pathway WP2355,0.8138528287550005,0.6809714540021616,0.1402635919258572,"['TGFB1', 'PRKCD', 'CRH']",0.9984282791802614,0,0,3
315,Glycerophospholipid Biosynthetic Pathway WP2533,0.8152130246385775,0.5964269862405681,0.12185350447636606,['CDIPT'],0.9984282791802614,0,0,1
316,Melatonin metabolism and effects WP3298,0.8152130246385775,0.5964269862405681,0.12185350447636606,['PER2'],0.9984282791802614,0,0,1
317,Gastrin signaling pathway WP4659,0.8209945524501772,0.697274031563845,0.13752949661306135,"['PRKCH', 'KAT5', 'CDKN2A', 'PRKCD']",0.9984282791802614,0,0,4
318,Ectoderm Differentiation WP2858,0.8234503636958096,0.7144578313253012,0.1387848669293484,"['MAFB', 'NR2F2', 'JAKMIP1', 'PTPN13', 'GLI3']",0.9984282791802614,0,0,5
319,Nanoparticle-mediated activation of receptor signaling WP2643,0.8272953319379607,0.5725166444740346,0.10854545466010293,['FN1'],0.9984282791802614,0,0,1
320,Neural Crest Differentiation WP2064,0.8299679097470752,0.6219130434782608,0.11590484052414933,"['ASCL1', 'GFAP']",0.9984282791802614,0,0,2
321,Pathways affected in adenoid cystic carcinoma WP3651,0.8299679097470752,0.6219130434782608,0.11590484052414933,"['MYCBP', 'FOXP2']",0.9984282791802614,0,0,2
322,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8368202822677593,0.649836145163248,0.11576567617255473,"['SHC3', 'GAB1', 'BAX']",0.9984282791802614,0,0,3
323,miRNA regulation of prostate cancer signaling pathways WP3981,0.8385886100417759,0.5504455597664653,0.09689769867202636,['TCF7'],0.9984282791802614,0,0,1
324,Prion disease pathway WP3995,0.8385886100417759,0.5504455597664653,0.09689769867202636,['HSPA5'],0.9984282791802614,0,0,1
325,ATM Signaling Pathway WP2516,0.8491443218944118,0.5300093702224195,0.08667037410840082,['GADD45A'],0.9984282791802614,0,0,1
326,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8491443218944118,0.5300093702224195,0.08667037410840082,['SUPT4H1'],0.9984282791802614,0,0,1
327,AMP-activated protein kinase (AMPK) signaling WP1403,0.8545311712313409,0.5836734693877551,0.09175481077364198,"['LEPR', 'HMGCR']",0.9984282791802614,0,0,2
328,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8545311712313409,0.5836734693877551,0.09175481077364198,"['TCF7', 'ACTG1']",0.9984282791802614,0,0,2
329,ESC Pluripotency Pathways WP3931,0.8573023369512643,0.6214082544842399,0.09567489655278259,"['GAB1', 'FGF1', 'IL6ST']",0.9984282791802614,0,0,3
330,Regulation of Actin Cytoskeleton WP51,0.8580859149435653,0.6736379480184891,0.10310099562809996,"['CHRM5', 'FN1', 'FGF1', 'MYLK', 'ACTG1']",0.9984282791802614,0,0,5
331,CAMKK2  Pathway WP4874,0.8590105780045414,0.5110329085029485,0.07766373708319772,['MAP1LC3A'],0.9984282791802614,0,0,1
332,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8590105780045414,0.5110329085029485,0.07766373708319772,['TGFB1'],0.9984282791802614,0,0,1
333,IL-5 signaling pathway WP127,0.8590105780045414,0.5110329085029485,0.07766373708319772,['SPRED1'],0.9984282791802614,0,0,1
334,Amyotrophic lateral sclerosis (ALS) WP2447,0.8682323546291041,0.49336516828137195,0.06971048065114183,['BAX'],0.9984282791802614,0,0,1
335,Ferroptosis WP4313,0.8682323546291041,0.49336516828137195,0.06971048065114183,['MAP1LC3A'],0.9984282791802614,0,0,1
336,IL-2 signaling pathway WP49,0.8682323546291041,0.49336516828137195,0.06971048065114183,['PTK2B'],0.9984282791802614,0,0,1
337,MET in type 1 papillary renal cell carcinoma WP4205,0.8758150222879016,0.5498461538461539,0.07290980460618483,"['RPL11', 'GAB1']",0.9984282791802614,0,0,2
338,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8768516976780653,0.4768752774079006,0.0626697103967791,['ACTG1'],0.9984282791802614,0,0,1
339,Netrin-UNC5B signaling pathway WP4747,0.8768516976780653,0.4768752774079006,0.0626697103967791,['PTK2B'],0.9984282791802614,0,0,1
340,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8768516976780653,0.4768752774079006,0.0626697103967791,['TGFB1'],0.9984282791802614,0,0,1
341,Vitamin D-sensitive calcium signaling in depression WP4698,0.8768516976780653,0.4768752774079006,0.0626697103967791,['PVALB'],0.9984282791802614,0,0,1
342,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8849079134685162,0.46144925046174995,0.056422180610400864,['GABRD'],0.9984282791802614,0,0,1
343,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8849079134685162,0.46144925046174995,0.056422180610400864,['CYCS'],0.9984282791802614,0,0,1
344,G Protein Signaling Pathways WP35,0.8864585068905444,0.5791505791505791,0.06979978384245684,"['PRKCH', 'PRKD3', 'PRKCD']",0.9984282791802614,0,0,3
345,Chemokine signaling pathway WP3929,0.8898430904309474,0.6075776538855387,0.07091046981700785,"['SHC3', 'PRKCD', 'PTK2B', 'CXCL14']",0.9984282791802614,0,0,4
346,IL-3 signaling pathway WP286,0.8924377468431522,0.4469873501997337,0.050866498552668706,['TGFB1'],0.9984282791802614,0,0,1
347,TGF-beta Receptor Signaling WP560,0.8924377468431522,0.4469873501997337,0.050866498552668706,['TGFB1'],0.9984282791802614,0,0,1
348,Glycogen Synthesis and Degradation WP500,0.8994755480683809,0.43340192874147604,0.04591607817776076,['PHKG1'],0.9984282791802614,0,0,1
349,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.906989927654637,0.5825602968460112,0.05687182799964259,"['DLX2', 'SST', 'TAC1', 'ASCL1']",0.9984282791802614,0,0,4
350,16p11.2 proximal deletion syndrome WP4949,0.910018565297835,0.4926896551724138,0.046455844678658036,"['SEZ6L2', 'CDIPT']",0.9984282791802614,0,0,2
351,Pathogenic Escherichia coli infection WP2272,0.9122014065420417,0.40856001521780483,0.03754440719859582,['ACTG1'],0.9984282791802614,0,0,1
352,Common Pathways Underlying Drug Addiction WP2636,0.9179475436591478,0.3971741381861222,0.03400407654156441,['ACTG1'],0.9984282791802614,0,0,1
353,PPAR signaling pathway WP3942,0.9179475436591478,0.3971741381861222,0.03400407654156441,['CD36'],0.9984282791802614,0,0,1
354,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9179475436591478,0.3971741381861222,0.03400407654156441,['TGFB1'],0.9984282791802614,0,0,1
355,DNA IR-damage and cellular response via ATR WP4016,0.9193061441210496,0.47617777777777776,0.04006373382292297,"['SEM1', 'ABRAXAS1']",0.9984282791802614,0,0,2
356,Glucocorticoid Receptor Pathway WP2880,0.9233180721266264,0.386403713966963,0.030827866742074064,['B3GNT5'],0.9984282791802614,0,0,1
357,RANKL/RANK signaling pathway WP2018,0.9233180721266264,0.386403713966963,0.030827866742074064,['PAPSS2'],0.9984282791802614,0,0,1
358,Leptin signaling pathway WP2034,0.931561893566589,0.4533756613756614,0.03214100031006828,"['LEPR', 'BAX']",0.9984282791802614,0,0,2
359,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9330287912561305,0.3665198538700536,0.02540687031716032,['MAP1LC3A'],0.9984282791802614,0,0,1
360,Joubert Syndrome WP4656,0.9352402850702466,0.44625,0.029877237773343578,"['KAT5', 'PDE6B']",0.9984282791802614,0,0,2
361,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9374133329362657,0.357323568575233,0.02309416894051657,['RPS6KA5'],0.9984282791802614,0,0,1
362,Mesodermal commitment pathway WP2857,0.941837255520287,0.4863757737589513,0.029144990517348816,"['SLC2A12', 'PBX3', 'RPL38']",0.9984282791802614,0,0,3
363,Fragile X Syndrome  WP4549,0.9425536780899716,0.5232301427660305,0.030955555394099433,"['CDKN2A', 'GAD1', 'GAB1', 'GABRD']",0.9984282791802614,0,0,4
364,EGF/EGFR signaling pathway WP437,0.9427514264963227,0.5523385531791247,0.032561810206878025,"['RPS6KA5', 'PRKCD', 'GAB1', 'PTK2B', 'ARF6']",0.9984282791802614,0,0,5
365,Cardiac Hypertrophic Response WP2795,0.9489204025617279,0.33230111788932587,0.01742266689261403,['TGFB1'],0.9984282791802614,0,0,1
366,Interferon type I signaling pathways WP585,0.9489204025617279,0.33230111788932587,0.01742266689261403,['RPS6KA5'],0.9984282791802614,0,0,1
367,22q11.2 copy number variation syndrome WP4657,0.9536622611764254,0.40777142857142856,0.019346998478703234,"['MRPL40', 'RELN']",0.9984282791802614,0,0,2
368,TGF-beta Signaling Pathway WP366,0.958935594310672,0.4502424285011594,0.018879279865153597,"['TGFB1', 'PARD6A', 'FN1']",0.9984282791802614,0,0,3
369,3q29 copy number variation syndrome WP4906,0.9610447577564077,0.3039068476074454,0.012075524927425444,['TGFB1'],0.9984282791802614,0,0,1
370,Rett syndrome causing genes WP4312,0.9610447577564077,0.3039068476074454,0.012075524927425444,['GABRD'],0.9984282791802614,0,0,1
371,ErbB signaling pathway WP673,0.9630355114601219,0.3855855855855856,0.014523077995124334,"['SHC3', 'GAB1']",0.9984282791802614,0,0,2
372,Androgen receptor signaling pathway WP138,0.9650775494131503,0.3804088888888889,0.01352232583785779,"['KAT5', 'ETV5']",0.9984282791802614,0,0,2
373,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9659819082128785,0.2914481371776407,0.010087070594872686,['IL6ST'],0.9984282791802614,0,0,1
374,Toll-like Receptor Signaling Pathway WP75,0.9659819082128785,0.2914481371776407,0.010087070594872686,['TIRAP'],0.9984282791802614,0,0,1
375,PI3K-Akt signaling pathway WP4172,0.9660916938663467,0.5498980310727131,0.018969572874246294,"['RELN', 'ANGPT2', 'IL7', 'FN1', 'VEGFB', 'COL6A6', 'FGF1']",0.9984282791802614,0,0,7
376,7q11.23 copy number variation syndrome WP4932,0.9670109256472974,0.3753684210526316,0.012591915773535231,"['UBE2L6', 'ATP5MC1']",0.9984282791802614,0,0,2
377,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9673940349532159,0.5468249870934435,0.018126911845758875,"['RELN', 'ANGPT2', 'COL5A1', 'COL5A2', 'FN1', 'VEGFB', 'FGF1']",0.9984282791802614,0,0,7
378,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9740458420812461,0.4109325254185067,0.010806255906298684,"['SLCO1C1', 'RPS6KA5', 'SHC3']",0.9984282791802614,0,0,3
379,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9757603467573811,0.2643389061498249,0.006486419206261834,['APEX1'],0.9984282791802614,0,0,1
380,Ras signaling WP4223,0.978377638064612,0.43784450843274375,0.009571084137574964,"['HTR7', 'SHC3', 'GAB1', 'ARF6']",0.9984282791802614,0,0,4
381,Thermogenesis WP4321,0.9791715681902111,0.33936507936507937,0.007143093090037647,"['ADCY10', 'ACTG1']",0.9984282791802614,0,0,2
382,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9803447973537427,0.33534117647058825,0.006656835951322898,"['TGFB1', 'FN1']",0.9984282791802614,0,0,2
383,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.983862887849607,0.23777185974256546,0.003868246961716484,['SLCO1C1'],0.9984282791802614,0,0,1
384,Amino Acid metabolism WP3925,0.9849211767835068,0.23385213158411736,0.0035530708491095975,['LDHA'],0.9984282791802614,0,0,1
385,Ciliopathies WP4803,0.9860463776407815,0.4091486169353287,0.005749311088310286,"['MAK', 'CCDC65', 'CCDC28B', 'GLI3']",0.9984282791802614,0,0,4
386,TNF-alpha signaling pathway WP231,0.9892590766921123,0.21603518540935318,0.002332969029333224,['BAX'],0.9984282791802614,0,0,1
387,Regulation of toll-like receptor signaling pathway WP1449,0.9912376606695003,0.20658445743839132,0.0018181403820762625,['TIRAP'],0.9984282791802614,0,0,1
388,Metapathway biotransformation Phase I and II WP702,0.9923499871810584,0.2007276682732882,0.0015414729257187164,['FMO5'],0.9984282791802614,0,0,1
389,Integrin-mediated Cell Adhesion WP185,0.993321229158879,0.1951917990624373,0.0013080141377554775,['SHC3'],0.9984282791802614,0,0,1
390,Genes related to primary cilium development (based on CRISPR) WP4536,0.9982830416186043,0.15292871153873688,0.0002627979041795704,['CDK20'],0.9999539186548989,0,0,1
391,Ciliary landscape WP4352,0.9999539186548989,0.15263423423423422,7.0337528856300904e-06,"['DOCK5', 'COPS7A']",0.9999539186548989,0,0,2
